Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    News Scan

    Biodefense Headlines – June 14, 2015

    By Global Biodefense StaffJune 14, 2015
    Biosecurity Headlines of the Week
    Share
    Facebook LinkedIn Reddit Email

    See what we’re reading this week at Global Biodefense on topics including disaster preparedness, China’s Ebola drug, nerve agent treatments and more…

    WHO calls emergency meeting on complex South Korea MERS outbreak (Reuters)

    Finding better treatments for nerve agents (Battelle)

    A Chinese Ebola Drug raises hopes, and rancor (NY Times)

    Upping our game for disaster preparedness and response (White House OSTP)

    Stealth attack: infection and disease on the battlefield (The Conversation)

    Lawmakers ask whether Homeland Security fumbled in fighting bioterror (WP)

    Research chimps to be listed as ‘endangered’ (Science)

    MERS virus’s path: One man, many South Korean hospitals (NY Times)

    Anthrax: Department of Defense laboratory review (DoD)

    As MERS outbreak surges, genetic tests show virus hasn’t mutated (NPR)

    G7 states vow to wipe out Ebola but offer little concrete action (Reuters)

    Anthrax scare: Remain calm, all is well (War on the Rocks)

    CDC says its investigation into listeria outbreak is over (Food Safety News)

    Ultrasensitive nanomechanical biosensor developed (MDT)

    Boldly going where no vaccine has gone before (Tracking Zebra)

    Microsoft is using drones to predict disease outbreaks (Nextgov)

    Accidental anthrax shipments follow a familiar pattern (LA Times)

    The devil you know vs. the devil you fear (The Bifurcated Needle)

    Most recent Ebola papers (PubMed)

    MERS outbreak in Korea may be past its peak, panel says (Science)

    West African travel-related illnesses: Not just Ebola (UPMC CBN)

    Ebola could hit again and we would hardly do better: MSF (Reuters)

    Share. Facebook LinkedIn Reddit Email
    Previous Article2 Mutations Identified as Critical for MERS Transmission
    Next Article HHS Selects Regional Special Pathogen Treatment Centers

    Related Stories

    Biodefense Headlines – 19 September 2023

    September 19, 2023

    Biodefense Headlines – 12 September 2023

    September 12, 2023

    Biodefense Headlines – 3 September 2023

    September 3, 2023

    Biodefense Headlines – 27 August 2023

    August 27, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    Oct 17
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.